P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Rayid Abdulqawi, Rachel Dockry, Kimberley Holt, Gary Layton, Bruce G. McCarthy, Anthony P. Ford, Jaclyn A. Smith

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1198-1205
Number of pages7
JournalThe Lancet
Issue number9974
Publication statusPublished - 28 Mar 2015

Cite this